BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20179297)

  • 21. Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling.
    Martin KA; Merenick BL; Ding M; Fetalvero KM; Rzucidlo EM; Kozul CD; Brown DJ; Chiu HY; Shyu M; Drapeau BL; Wagner RJ; Powell RJ
    J Biol Chem; 2007 Dec; 282(49):36112-20. PubMed ID: 17908691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions.
    Matthew EM; Hart LS; Astrinidis A; Navaraj A; Dolloff NG; Dicker DT; Henske EP; El-Deiry WS
    Cell Cycle; 2009 Dec; 8(24):4168-75. PubMed ID: 20054236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammalian target of rapamycin is activated in association with myometrial proliferation during pregnancy.
    Jaffer S; Shynlova O; Lye S
    Endocrinology; 2009 Oct; 150(10):4672-80. PubMed ID: 19589861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significantly decreased P27 expression in endometrial carcinoma compared to complex hyperplasia with atypia (correlation with p53 expression).
    Ozkara SK; Corakci A
    Pathol Oncol Res; 2004; 10(2):89-97. PubMed ID: 15188025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).
    Rolfe M; McLeod LE; Pratt PF; Proud CG
    Biochem J; 2005 Jun; 388(Pt 3):973-84. PubMed ID: 15757502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
    Zhang HZ; Li XH; Zhang X; Zhang ZY; Meng YL; Xu SW; Zheng Y; Zhu ZL; Cui DS; Huang LX; Yan BY; Sun XF
    Chemotherapy; 2010; 56(4):291-7. PubMed ID: 20714146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central insulin signaling is attenuated by long-term insulin exposure via insulin receptor substrate-1 serine phosphorylation, proteasomal degradation, and lysosomal insulin receptor degradation.
    Mayer CM; Belsham DD
    Endocrinology; 2010 Jan; 151(1):75-84. PubMed ID: 19887566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies.
    Shah OJ; Wang Z; Hunter T
    Curr Biol; 2004 Sep; 14(18):1650-6. PubMed ID: 15380067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.
    Bircan S; Ensari A; Ozturk S; Erdogan N; Dundar I; Ortac F
    Pathol Oncol Res; 2005; 11(1):32-9. PubMed ID: 15800680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
    Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
    Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR.
    Dere R; Wilson PD; Sandford RN; Walker CL
    PLoS One; 2010 Feb; 5(2):e9239. PubMed ID: 20169078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway.
    Zhang HH; Huang J; Düvel K; Boback B; Wu S; Squillace RM; Wu CL; Manning BD
    PLoS One; 2009 Jul; 4(7):e6189. PubMed ID: 19593385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evodiamine inhibits insulin-stimulated mTOR-S6K activation and IRS1 serine phosphorylation in adipocytes and improves glucose tolerance in obese/diabetic mice.
    Wang T; Kusudo T; Takeuchi T; Yamashita Y; Kontani Y; Okamatsu Y; Saito M; Mori N; Yamashita H
    PLoS One; 2013; 8(12):e83264. PubMed ID: 24391749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A chronic increase in physical activity inhibits fed-state mTOR/S6K1 signaling and reduces IRS-1 serine phosphorylation in rat skeletal muscle.
    Glynn EL; Lujan HL; Kramer VJ; Drummond MJ; DiCarlo SE; Rasmussen BB
    Appl Physiol Nutr Metab; 2008 Feb; 33(1):93-101. PubMed ID: 18347658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mTOR partly mediates insulin resistance by phosphorylation of insulin receptor substrate-1 on serine(307) residues after burn.
    Xin-Long C; Zhao-Fan X; Dao-Feng B; Wei D
    Burns; 2011 Feb; 37(1):86-93. PubMed ID: 20594757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells.
    Andreozzi F; D'Alessandris C; Federici M; Laratta E; Del Guerra S; Del Prato S; Marchetti P; Lauro R; Perticone F; Sesti G
    Endocrinology; 2004 Jun; 145(6):2845-57. PubMed ID: 15001544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling.
    Gao S; Duan C; Gao G; Wang X; Yang H
    Int J Biochem Cell Biol; 2015 Jul; 64():25-33. PubMed ID: 25813876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of focal adhesion kinase with tuberous sclerosis complex 2 in the regulation of s6 kinase activation and cell growth.
    Gan B; Yoo Y; Guan JL
    J Biol Chem; 2006 Dec; 281(49):37321-9. PubMed ID: 17043358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
    Fang CX; Yang X; Sreejayan N; Ren J
    Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.
    Zhang SQ; Cai B; Liu L; He YY; Yang YX; Wan XP
    Int J Gynecol Cancer; 2009 Nov; 19(8):1377-83. PubMed ID: 20009893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.